Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Essential,Hypertension”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01456169
What this trial is testing

Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone

Who this might be right for
Essential Hypertension
Takeda 507
Not applicableStudy completedNCT03855605
What this trial is testing

Diagnosis of Hypertension by Home Blood Pressure Monitoring

Who this might be right for
Hypertension,EssentialHome Blood PressureAmbulatory Blood Pressure
DongGuk University 470
Post-approval studies (Phase 4)Study completedNCT02079805
What this trial is testing

Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R

Who this might be right for
Essential Hypertension Complicated by Type 2 Diabetes Mellitus
Takeda 33
Large-scale testing (Phase 3)Study completedNCT05930028
What this trial is testing

Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia

Who this might be right for
Essential HypertensionPrimary Hypercholesterolemia
Boryung Pharmaceutical Co., Ltd 148
Post-approval studies (Phase 4)Study completedNCT00457483
What this trial is testing

Nijmegen Antihypertensive Management Improvement Study

Who this might be right for
Primary Hypertension
Radboud University Medical Center 120
Large-scale testing (Phase 3)Study completedNCT00696241
What this trial is testing

Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension

Who this might be right for
Hypertension
Takeda 1,275
Post-approval studies (Phase 4)Study completedNCT03344159
What this trial is testing

Spironolactone Therapy in Chronic Stable Right HF Trial

Who this might be right for
Chronic Right-Sided Heart FailurePulmonary Arterial HypertensionPulmonary Hypertension, Primary, 2+3 more
Ottawa Heart Institute Research Corporation 15
Large-scale testing (Phase 3)Study completedNCT00591253
What this trial is testing

Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension

Who this might be right for
Hypertension
Takeda 413
Not applicableStudy completedNCT05092672
What this trial is testing

Physical Activity, Air Pollution, and High Blood Pressure

Who this might be right for
Essential Hypertension
University of British Columbia 21
Large-scale testing (Phase 3)Study completedNCT06395194
What this trial is testing

Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension

Who this might be right for
Essential Hypertension
Oslo University Hospital 15,313
Not applicableStudy completedNCT07257237
What this trial is testing

Sleep Hygiene Education and Blood Pressure Control in Essential Hypertension in Primary Care

Who this might be right for
Essential HypertensionSleep QualityPrimary Care
Ozturk Gurer Tutu, MD 138
Not applicableUnknownNCT01617551
What this trial is testing

Effect of Renal Denervation on NO-mediated Sodium Excretion and Plasma Levels of Vasoactive Hormones

Who this might be right for
Essential Hypertension
Regional Hospital Holstebro 30
Post-approval studies (Phase 4)Study completedNCT01071122
What this trial is testing

FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)

Who this might be right for
Hypertension
Bayer 365
Large-scale testing (Phase 3)Study completedNCT03514641
What this trial is testing

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

Who this might be right for
Essential Hypertension
Theracos 673
Early research (Phase 1)Study completedNCT00991705
What this trial is testing

Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 28
Post-approval studies (Phase 4)Study completedNCT00487123
What this trial is testing

Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months

Who this might be right for
Hypertension
Novartis
Not applicableNot Yet RecruitingNCT07685054
What this trial is testing

To Evaluate the Renal Protective Effects and Safety of 'Fimasartan and Atorvastatin' or 'Fimasartan, Atorvastatin and Ezetimibe'.

Who this might be right for
Essential HypertensionPrimary Hypercholesterolemia
Boryung Pharmaceutical Co., Ltd 12,700
Not applicableStudy completedNCT03261375
What this trial is testing

To Evaluate Safety and Efficacy of a Radiofrequency Renal Denervation System in Treatment of Essential Hypertension

Who this might be right for
Hypertension
Shanghai Golden Leaf MedTec Co. Ltd 205
Large-scale testing (Phase 3)Study completedNCT05820880
What this trial is testing

Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension

Who this might be right for
Hypertension
Institut de Recherches Internationales Servier 532
Early research (Phase 1)Ended earlyNCT02245230
What this trial is testing

Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension

Who this might be right for
HypertensionHypertension, Essential
Vanderbilt University 24
Next Page